BRPI0921156A2 - inibidores de pi3k/mtor quinase - Google Patents
inibidores de pi3k/mtor quinaseInfo
- Publication number
- BRPI0921156A2 BRPI0921156A2 BRPI0921156A BRPI0921156A BRPI0921156A2 BR PI0921156 A2 BRPI0921156 A2 BR PI0921156A2 BR PI0921156 A BRPI0921156 A BR PI0921156A BR PI0921156 A BRPI0921156 A BR PI0921156A BR PI0921156 A2 BRPI0921156 A2 BR PI0921156A2
- Authority
- BR
- Brazil
- Prior art keywords
- pi3k
- kinase inhibitors
- mtor kinase
- mtor
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19901908P | 2008-11-11 | 2008-11-11 | |
| US21482809P | 2009-04-28 | 2009-04-28 | |
| PCT/US2009/006071 WO2010056320A2 (en) | 2008-11-11 | 2009-11-11 | Pi3k/mtor kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0921156A2 true BRPI0921156A2 (pt) | 2016-02-23 |
Family
ID=42170586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0921156A BRPI0921156A2 (pt) | 2008-11-11 | 2009-11-11 | inibidores de pi3k/mtor quinase |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8586582B2 (pt) |
| EP (1) | EP2382207B1 (pt) |
| JP (1) | JP5877064B2 (pt) |
| KR (1) | KR20110098908A (pt) |
| CN (1) | CN102264732A (pt) |
| AU (1) | AU2009314544C1 (pt) |
| BR (1) | BRPI0921156A2 (pt) |
| CA (1) | CA2743015A1 (pt) |
| ES (1) | ES2539478T3 (pt) |
| WO (1) | WO2010056320A2 (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2250160B1 (en) | 2008-01-25 | 2015-11-11 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| CA2750935A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| EP2483272A4 (en) * | 2009-09-29 | 2013-09-18 | Xcovery Holding Co Llc | SELECTIVE PI3K (DELTA) INHIBITOR |
| DE102009049679A1 (de) * | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
| JP2013529212A (ja) * | 2010-05-19 | 2013-07-18 | エクスカバリー ホールディング カンパニー，エルエルシー | ｍＴＯＲ選択的キナーゼ阻害剤 |
| MA34797B1 (fr) | 2010-08-11 | 2014-01-02 | Millennium Pharm Inc | Hétéroaryles et leurs utilisations |
| EP2603216A4 (en) | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | HETEROARYLE AND USES THEREOF |
| US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| EP2627181A4 (en) | 2010-10-13 | 2014-03-19 | Millennium Pharm Inc | HETEROARYLE AND USES THEREOF |
| AP2013007043A0 (en) * | 2011-01-31 | 2013-08-31 | Novartis Ag | Novel heterocyclic derivatives |
| WO2012136622A1 (en) | 2011-04-04 | 2012-10-11 | Cellzome Limited | Dihydropyrrolo pyrimidine derivatives as mtor inhibitors |
| FR2986232B1 (fr) * | 2012-01-26 | 2014-02-14 | Sanofi Sa | Derives heterocycliques bicycliques, leur preparation et leur application en therapeutique |
| WO2013138860A1 (en) * | 2012-03-22 | 2013-09-26 | Biota Europe Limited | Antibacterial compounds |
| CN103374021B (zh) * | 2012-04-21 | 2015-10-28 | 通化济达医药有限公司 | 含有锌结合基的吡啶并嘧啶类HDAC和mTOR抑制剂 |
| CN104870017B (zh) | 2012-11-08 | 2020-08-14 | 理森制药股份公司 | 含有PDE4抑制剂和PI3δ或双重PI3δ-γ激酶抑制剂的药物组合物 |
| EP2733143A1 (en) * | 2012-11-14 | 2014-05-21 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands |
| JP6139789B2 (ja) | 2013-10-16 | 2017-05-31 | シャンハイ インリ ファーマシューティカル カンパニー リミティド | 縮合複素環化合物、その調製方法、医薬組成物及びその使用 |
| WO2015155624A1 (en) | 2014-04-10 | 2015-10-15 | Pfizer Inc. | Dihydropyrrolopyrimidine derivatives |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| CN108473472B (zh) | 2015-10-02 | 2021-02-12 | 圣提内尔肿瘤学有限公司 | 作为p70s6激酶抑制剂的2-氨基喹唑啉衍生物 |
| US20230079863A1 (en) * | 2021-03-29 | 2023-03-16 | Gilead Sciences, Inc. | Khk inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL175327B1 (pl) * | 1992-04-03 | 1998-12-31 | Upjohn Co | Dwupierścieniowe heterocykliczne aminy |
| US5502187A (en) * | 1992-04-03 | 1996-03-26 | The Upjohn Company | Pharmaceutically active bicyclic-heterocyclic amines |
| US8763081B2 (en) * | 2006-04-03 | 2014-06-24 | Bridgeport Networks, Inc. | Network based authentication |
| KR101402474B1 (ko) * | 2006-04-26 | 2014-06-19 | 제넨테크, 인크. | 포스포이노시티드 3-키나제 억제제 화합물 및 이를 포함하는 약학적 조성물 |
| AU2007282535B9 (en) * | 2006-08-08 | 2013-06-20 | Chugai Seiyaku Kabushiki Kaisha | Pyrimidine derivative as PI3K inhibitor and use thereof |
| US20080234262A1 (en) * | 2007-03-21 | 2008-09-25 | Wyeth | Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| DK2209786T3 (da) * | 2007-10-05 | 2013-06-03 | Verastem Inc | Pyrimidinsubstituerede purinderivater |
| CL2009000241A1 (es) * | 2008-02-07 | 2010-09-03 | Chugai Pharmaceutical Co Ltd | Compuestos derivados de 5-(2-morfolin-4-il-7h-pirrolo[2,3-d]pirimidin-4-il)pirimidin-2-ilamina; proceso de preparacion; composicion farmaceutica; y uso de los compuestos para tratar o prevenir una enfermedad proliferativa tal como el cancer. |
| DE102009049679A1 (de) | 2009-10-19 | 2011-04-21 | Merck Patent Gmbh | Pyrazolopyrimidinderivate |
-
2009
- 2009-11-11 BR BRPI0921156A patent/BRPI0921156A2/pt not_active IP Right Cessation
- 2009-11-11 CA CA2743015A patent/CA2743015A1/en not_active Abandoned
- 2009-11-11 CN CN2009801529113A patent/CN102264732A/zh active Pending
- 2009-11-11 AU AU2009314544A patent/AU2009314544C1/en not_active Ceased
- 2009-11-11 EP EP20090826421 patent/EP2382207B1/en not_active Not-in-force
- 2009-11-11 ES ES09826421.1T patent/ES2539478T3/es active Active
- 2009-11-11 JP JP2011535571A patent/JP5877064B2/ja not_active Expired - Fee Related
- 2009-11-11 US US13/128,687 patent/US8586582B2/en not_active Expired - Fee Related
- 2009-11-11 WO PCT/US2009/006071 patent/WO2010056320A2/en active Application Filing
- 2009-11-11 KR KR1020117013404A patent/KR20110098908A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US8586582B2 (en) | 2013-11-19 |
| WO2010056320A3 (en) | 2010-09-16 |
| ES2539478T3 (es) | 2015-07-01 |
| AU2009314544C1 (en) | 2015-11-12 |
| EP2382207A2 (en) | 2011-11-02 |
| WO2010056320A2 (en) | 2010-05-20 |
| JP5877064B2 (ja) | 2016-03-02 |
| CA2743015A1 (en) | 2010-05-20 |
| AU2009314544B2 (en) | 2015-07-30 |
| CN102264732A (zh) | 2011-11-30 |
| AU2009314544A1 (en) | 2010-05-20 |
| KR20110098908A (ko) | 2011-09-02 |
| EP2382207B1 (en) | 2015-04-29 |
| EP2382207A4 (en) | 2012-09-12 |
| US20110281857A1 (en) | 2011-11-17 |
| JP2012508236A (ja) | 2012-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0921156A2 (pt) | inibidores de pi3k/mtor quinase | |
| CY2019027I2 (el) | Παραγωγα φωσφορου ως αναστολεις κινασης | |
| CY2019009I1 (el) | Αναστολεις πρωτεϊνικων κινασων | |
| CY2020023I2 (el) | Αναστολεiς βητα-λακταμασων | |
| BRPI0811434A2 (pt) | imidazopiridazinas como inibidores de pi3k lipídeo cinase. | |
| BRPI0908494A2 (pt) | Inibidores de pirrolopirazina quinase | |
| ATE519763T1 (de) | Pyrrolopyrazin-kinasehemmer | |
| BRPI0913580A2 (pt) | pirrolopiridinas como inibidores de quinase | |
| BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
| BRPI0910668A2 (pt) | inibidores de proteína quinases | |
| BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
| BRPI0918846A2 (pt) | inibidores de cinase heterocíclica | |
| BRPI0807893A2 (pt) | Imidazoquinolinas como inibidores duais de lipídio quinase e mtor. | |
| BRPI1009112A2 (pt) | inibidores de tirosina quinase de bruton | |
| BRPI1011129A2 (pt) | métodos e compostos inibidores de janus cinase | |
| BRPI0916295A2 (pt) | inibidores de pirazolopiridina tricíclica cinase | |
| ATE506358T1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
| CR10369A (es) | Pyrimidine derivatives as pi3k inhibitors | |
| BRPI0810374A2 (pt) | Inibidores específicos do pdgfrbeta | |
| ES2598358T8 (es) | Derivados de quinolina como inhibidores de PI3K quinasa | |
| BRPI0716781A2 (pt) | Inibidores da quinase | |
| BRPI0917808A2 (pt) | inibidores de cmet | |
| DK2414362T3 (da) | Pyrimidinsubstituerede purinforbindelser som kinaseinhibitorer | |
| BRPI0717928A2 (pt) | Imidazopiridazinas como inibidores da cinase de lipídio pi3k | |
| BRPI0922880A2 (pt) | compostos inibidores de quinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |